Reply: Loperamide-Associated Ventricular Arrhythmias
J Am Coll Cardiol
.
2023 Oct 24;82(17):e159.
doi: 10.1016/j.jacc.2023.07.033.
Authors
Mori J Krantz
1
,
Norman Stockbridge
2
,
David P Kao
3
,
Michael G Klein
4
,
Mark C P Haigney
4
Affiliations
1
U.S. Food and Drug Administration, Silver Spring, Maryland, USA. Electronic address: Mori.krantz@fda.hhs.gov.
2
U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
3
University of Colorado School of Medicine, Aurora, Colorado, USA.
4
Uniformed Services University, Cardiology, Bethesda, Maryland, USA.
PMID:
37852701
DOI:
10.1016/j.jacc.2023.07.033
No abstract available
Publication types
Letter
Comment
MeSH terms
Arrhythmias, Cardiac / chemically induced
Drug Overdose*
Humans
Loperamide* / adverse effects
Substances
Loperamide